POTENZA, ALESSIA
 Distribuzione geografica
Continente #
EU - Europa 72
NA - Nord America 59
AS - Asia 31
AF - Africa 2
SA - Sud America 2
Totale 166
Nazione #
US - Stati Uniti d'America 59
IT - Italia 30
ID - Indonesia 12
CH - Svizzera 10
HK - Hong Kong 10
IE - Irlanda 8
SG - Singapore 8
SE - Svezia 7
DE - Germania 5
RU - Federazione Russa 5
ES - Italia 2
FR - Francia 2
GB - Regno Unito 2
GH - Ghana 2
PE - Perù 2
CN - Cina 1
UA - Ucraina 1
Totale 166
Città #
Fairfield 15
Dublin 8
Hong Kong 8
Jakarta 8
Milan 8
Singapore 8
Zurich 6
Cambridge 5
Cagliari 4
Princeton 4
Wilmington 4
Ferrara 3
Houston 3
Santa Clara 3
Woodbridge 3
Accra 2
Andover 2
Ann Arbor 2
Ashburn 2
Azzano San Paolo 2
Brescia 2
Chicago 2
Frankfurt am Main 2
Lima 2
Montecchio Maggiore 2
Basel 1
Berlin 1
Bologna 1
Ciampino 1
Corridonia 1
Falls Church 1
Geneva 1
Lawrence 1
Lübeck 1
Nashville 1
Norwalk 1
Oberentfelden 1
Osnago 1
Phoenix 1
Rome 1
Seattle 1
Shanghai 1
Toulouse 1
Totale 128
Nome #
Effector T cells co-expressing PD1 and CD39 are enriched in colorectal tumors: implications for cancer immunotherapy 93
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 75
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 6
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 4
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR 4
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 4
Correction to: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B (Nature Immunology, (2022), 23, 9, (1379-1392), 10.1038/s41590-022-01290-3) 4
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 3
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 3
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 3
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 3
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors 3
Totale 205
Categoria #
all - tutte 800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 26 5 8 2 3 3
2021/202212 0 2 2 2 0 1 0 0 1 0 0 4
2022/202320 5 5 2 0 0 4 0 0 0 0 2 2
2023/202442 0 0 0 0 11 2 6 7 4 4 3 5
2024/202584 8 11 6 10 4 45 0 0 0 0 0 0
Totale 205